Ahmedabad: Senores Pharmaceuticals has announced that it has received marketing authorizations from the Philippine Food and Drug Administration (FDA) for a basket of 10 products across Therapies like Cardiovascular, CNS, and Pain management, etc.

This marks a significant step in the company’s strategy to expand its footprint in Southeast Asia and enhance access to affordable healthcare. The approvals provide Senores Pharmaceuticals with a strong platform to serve the Philippines.

The market size of these particular drugs in the Philippines is valued at US $23 million, underscoring the immense opportunity for growth and patient impact.

“These approvals reaffirm our commitment to delivering high-quality, affordable treatments for patients,” said Swapnil Shah, Managing Director of Senore

See Full Page